Tritium labeling of full-length small interfering RNAs

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 55, Issue 6, 2012, Pages 189-196

  Christensen, Jesper ^a   Natt, François ^a   Hunziker, Jürg ^a   Krauser, Joel ^a   Andres, Hendrik ^a   Swart, Piet ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

final step radiolabeling; halogen tritium exchange; oligonucleotides; siRNA; tritiation

Indexed keywords

CHARCOAL; TRITIUM;

ANTISENSE; BUILDING BLOCKES; FINAL STEP RADIOLABELING; HALOGEN/TRITIUM EXCHANGE; LABELINGS; RADIOLABELLING; SIMPLE++; SIRNA; SMALL INTERFERING RNA; TRITIATION;

OLIGONUCLEOTIDES;

BROXURIDINE; DOUBLE STRANDED RNA; PHOSPHORAMIDOUS ACID; SMALL INTERFERING RNA; TRITIUM;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; IN VIVO STUDY; ISOTOPE LABELING; NUCLEOTIDE SEQUENCE;

EID: 84862740753     PISSN: 03624803     EISSN: 10991344     Source Type: Journal    
DOI: 10.1002/jlcr.2919     Document Type: Article

References (22)

1. A. Fire, S. Q. Xu, M. K. Montgomery, S. A. Kostas, S. E. Driver, C. C. Mello, Nature 1998, 391 (6669), 806-811.
2. A. Malek, F. Czubayk, A. Aigner, J. Drug Target. 2008, 16 (2), 124-139.
3. S. Gao, F. Dagnaes-Hansen, E. J. B. Nielsen, J. Wengel, F. Besenbacher, K. A. Howard, J. Kjems, Mol. Ther. 2009, 17 (7), 1225-1233.
4. A. Khan, M. Benboubetra, P. Z. Sayyed, K. W. Ng, S. Fox, G. Beck, I. F. Benter, S. Akhtar, J. Drug Target. 2004, 12 (6), 393-404.
5. S. Akhtar, S. Basu, E. Wickstrom, R. L. Juliano, Nucl. Acids Res. 1991, 19 (20), 5551-5559.
6. K. Yanagihara, M. Tashiro, Y. Fukuda, H. Ohno, Y. Higashiyama, Y. Miyazaki, Y. Hirakata, K. Tomono, Y. Mizuta, K. Tsukamoto, S. Kohno, J. Antimicrob. Chemother. 2006, 57 (1), 122-126.
7. G. Beale, A. J. Hollins, M. Benboubetra, M. Sohail, S. P. Fox, I. Benter, S. Akhtar, J. Drug Target. 2003, 11 (7), 449-456.
8. 14C]GSK2402968 (PRO051) a phosphorothioated exon skipping oliogonucleotide in CD-1 and mdx mice. DMDG Open Meeting 2011.
9. M. J. Graham, S. M. Freier, R. M. Crooke, D. J. Ecker, R. N. Maslova, E. A. Lesnik, Nucl. Acids Res. 1993, 21 (16), 3737-3743.
10. S. Agrawal, J. Temsamani, J. Y. Tang, Proc. Natl. Acad. Sci. U.S.A. 1991, 88 (17), 7595-7599.
11. T. Ledoan, R. Auger, A. Benjahad, J. P. Tenu, Nucleosides Nucleotides Nucleic Acids 1999, 18 (2), 277-289.
12. O. R. Mook, F. Baas, M. B. de Wissel, K. Fluiter, Mol. Cancer Ther. 2007, 6 (3), 833-843.
13. O. R. F. Mook, J. Vreijling, S. Wengel, J. Wengel, C. Zhou, J. Chattopadhyaya, F. Baas, K. Fluiter, Artificial DNA: PNA & XNA 2010, 1 (1), 36-44.
14. H. Sands, L. J. Gorey-Feret, A. J. Cocuzza, F. W. Hobbs, D. Chidester, G. L. Trainor, Mol. Pharmacol. 1994, 45 (5), 932-943.
15. W. T. Tan, R. P. Iyer, D. Yu, S. Agrawal, Tetrahedron Lett. 1995, 36 (21), 3631-3634.
16. P. J. Swart, E. Beljaars, C. Smit, A. Pasma, H. Schuitemaker, D. K. F. Meijer, J. Drug Target. 1996, 4 (2), 109- 116.
17. M. J. Robins, S. R. Naik, Biochemistry 1971, 10 (19), 3591-3597.
18. H. Grosjean, Nucleic acids are not boring long polymers of only four types of nucleotides: a guided tour. In DNA and RNA Modification Enzymes: Structure, Mechanism, Function and Evolution, (Ed.:, H. Grosjean,), Landes Bioscience: Austin, USA, 2009, pp. 1-18.
19. J. K. Watts, G. F. Deleavey, M. J. Damha, Drug Discov. Today 2008, 13 (19-20), 842-855.
20. F. M. van de Water, O. C. Boerman, A. C. Wouterse, J. G. P. Peters, F. G. M. Russel, R. Masereeuw, Drug Metab. Dispos. 2006, 34 (8), 1393-1397.
21. S. Noll, E. Mittag, React Kinet Catal L 1983, 22 (1-2), 35-37.
22. E. A. Evans, H. C. Sheppard, J. C. Turner, J Labelled Compd 1970, 6 (1), 76-87.